Keynote Speech Direction & Guidance on Pharmaceutical Industry Development : ASEAN Harmonization on GMP-PIC/S Requirements
|
|
- Loren Houston
- 6 years ago
- Views:
Transcription
1 Keynote Speech Direction & Guidance on Pharmaceutical Industry Development : ASEAN Harmonization on GMP-PIC/S Requirements Yuppadee JAVROONGRIT, Ph.D. Senior Expert on Pharmaceuticals Standard Food and Drug Administration (ThaiFDA) Ministry of Public Health, THAILAND GMP-PIC/S Thailand-PIC/S Accession-What s the Learning Curve The Novotel Platinum Pratunam Hotel, BKK, Thailand 19 September 2016
2 Presentation Outline PPWG- ASEAN Harmonization ASEAN PPWG-MRA on GMP Inspection PPWG vs. ICH vs. PIC/S Direction & Guidance
3 Presentation Outline PPWG- ASEAN Harmonization ASEAN PPWG-MRA on GMP Inspection PPWG vs. ICH vs. PIC/S Direction & Guidance
4 ASEAN = Association of Southeast Asian Nations Established = 8 Aug Size ~ 4.5 mil.km 2 ASEAN population ~ 600 million
5 Three Pillars of ASEAN Community
6 ASEAN Economic Community
7 The Goal on Economic ASEAN Leader Summit ASEAN Economic Community (AEC) by the year ASEAN will be Single Market and Single Production Base Free flow of Goods Free flow of Services Free flow of Investment Free flow of Capitals Free flow of Skilled Labour
8 Leader s Mandate to accelerate ASEAN Harmonization towards AEC for 12 Priority Products Healthcare Agro-based products Air traveling Automotive e-asean sectors Electronic & Electric Equip. Fisheries Logistics Textiles and apparels Tourism Rubber-based products Wood-based product 8
9 the AEC Aim create stable, prosperous, and highly competitive ASEAN Economic region Shall :- establish ASEAN as Single Market and Production base institute new mechanisms and measures to strengthen the implementation of its existing economic initiatives AFTA, AFAS, and AIA accelerate regional integration in the Priority sector improve the Dispute Settlement Mechanism AFTA = ASEAN Free Trade Area AFAS = ASEAN Framework Agreement on Services AIA = ASEAN Investment Area
10 1. Single Market & Production Base 2. High Competitive Economic Region free flow of Goods free flow of Services free flow of Investment free flow of Skilled Labour free flow of Capitals AEC 2015 e-asean tax & tariff competitiveness IPR Consumer protection Infrastructure Development 3. Equitable Economic Development bridging Old & New Members SMEs 4. Fully integrated into Global Economy FTAs with Non-ASEAN enhance Economic Cooperation Ref. Dept. of Trade Negotiation, Thailand 10
11 AEC the Measures/Mandates ASEAN Charter AEC Blueprint AEC Scorecard ASEAN Good Regulatory Practice (GRP) ASEAN Trade Facilitation Work Programme ASEAN Trade in Goods Agreement (ATIGA) Establishment.. 1. Legal unit 2. ACB (ASEAN Compliance Body) 3. ACT (ASEAN Consultation to Solve Trade and Investment Issues)
12 ASEAN International Cooperation
13 5 FTAs of ASEAN & Partners AJCEP * Goods /Services / Investment AANZFTA * Goods / Services/ Investment ACFTA Goods/ Services / Investment AJCEP = ASEAN-Japan Comprehensive Economic Partnership Agreement AIFTA * Goods * Services/ Investment - negotiating AKFTA Goods / Services / Investment
14 The ASEAN- Cooperation ASEAN Summit Economic Cooperation (AEC) AEM SEOM ACCSQ WG1 - Mutual Recognition Arrangements (MRAs) & Standards WG2 - Accreditation and Conformity Assessment WG3 - Scientific/Industrial Metrology ACC - ASEAN Committee on Cosmetic PPWG - Pharmaceuticals PWG Pf PWG - Prepared Foodstuff PWG TMHS PWG - Traditional Medicine & Health Supplement PWG Medical Devices&Equipment PWG EE PWG- Electrical and Electronic PWG A PWG - Automotives PWG RB PWG - Rubber-based PWG. - Political & Security Cooperation (APSC) - Socio-cultural Cooperation (ASCC) AHMM ASCC Council ASOD SOMHD AWGPD ASEAN Working Gr. on Pharmaceuticals Dev. ASEAN Sectoral Working on Traditional Medicine Initiatives on Traditional Medicine ThaiFDA proactive role in ASEAN AEC continue Proactive on POST 2015 Activities!
15 PPWG ACCSQ/PPWG ASEAN Consultative Committee for Standards and Quality / Pharmaceutical Product Working Group Objective: to develop harmonization scheme of Pharmaceuticals regulations of the ASEAN member countries, to complement and facilitate the objective of AFTA, particularly, the elimination of Technical Barriers to Trade posed by the regulations, without compromising on drug quality, efficacy, and safety 15
16 Pharmaceuticals PWG (PPWG) Principle to promote Registration, Trade, & Co-operation to eliminate TBT Scope to harmonize ASEAN Pharmaceutical Registration Output ASEAN Harmonized Product (ACTR, ACTD, guidelines) Mutual Recognition Agreement (MRA)
17 The PPWG Lead country & Assignment (1) Chair country : Malaysia Co-Chair country : Thailand ACTR : Quality Indonesia Safety Philippines Efficacy Thailand ACTR-Guidelines : Analytical Validation Thailand BA/BE Studies Malaysia Process Validation Singapore Stability Study Indonesia
18 The PPWG Lead country & Assignment (2) ACTD : Overall ACTD & ACTD Organization Thailand Administrative & Glossary Malaysia Quality Indonesia Non-Clinical Philippines Clinical /Efficacy Thailand IWG : Singapore (Chair) Indonesia (Co-Chair) MRA-GMP : Singapore / Malaysia (Co-Chairs) MRA-BA/BE: Indonesia / Malaysia (Co-Chairs) Post-marketing Alert System (PMAS): Singapore / Malaysia Biologics coop. Indonesia/Singapore
19 The PPWG Recognition & Agreement to facilitate AFTA & AEC to eliminate Technical Barrier to Trade (TBT) to align to International Standards without compromising on Q, S, E of Pharmaceuticals Product License the Decision of individual Member Country
20 Agreement of the ASEAN PPWG & ASEAN GMP MRA!
21 Working Scheme of the PPWG Comparative study on Registration Requirement & Regulation Identification the Key Area on Requirements for Harmonization the Works - Lead Countries /Members - Tech. discussion gr. -Dialogue w/ Association -IWG -MRA Task forces /JSC -HOD -Plenary PWG Endorsement (ACCSQ / SEOM / AEM / ) the Meetings Agreement (ASEAN Harmonized Product, MRAs) Implementation Capacity Building/Strengthening Agreement * ACTR, ACTD, Technical guidelines * Full implementation timeline * ASEAN Sectoral MRA on GMP Inspection * PMAS * Variation guideline Current Activities * Implementing ASEAN Har.products - for new application - for existing Drug license (by 2012) * GMP-MRA JSC Listed GMP Inspectorate Unit * MRA-BA/BE Study Report * Updating Tech.gls. * New areas of integration: Biological, Biotech., Biosimilar product * Facilitating the AEC * Coop. international forum: WHO, ICH, etc. * Training activities
22 Presentation Outline PPWG- ASEAN Harmonization ASEAN PPWG-MRA on GMP Inspection PPWG vs. ICH vs. PIC/S Direction & Guidance
23 ASEAN PPWG MRA on GMP Inspection (1) Formation of ASEAN MRA Taskforce(TF) on GMP Inspection * by PPWG/ACCSQ in 2005 * Chair by Singapore / Co-Chair by Malaysia ASEAN Sectoral MRA on GMP Inspection * signed by AEM on 10 Apr.2009, Pattaya, Thailand * PIC/S Framework, as Basis for the MRA * scope on GMP Report of Finished Dosage Forms for Registration (excludes APIs, Biologics, CT products, Herbal Med.) * Obligation: - AMS obliged to operate a PIC/S-equivalent GMP Inspection Framework - AMS obliged to accept GMP Certificates/Reports issued by Listed Inspection Services (i.e. AMS that meets PIC/S requirement) Ref. Mr.Sia Chong Hock/Chair of JSC GMP MRA
24 ASEAN PPWG MRA on GMP Inspection (2) Formation of JSC * by PPWG/ACCSQ in 2012, in which the TF was dissolved. * to implement the signed the GMP MRA * to establish an ASEAN Register of Listed Inspection Services (LIS) ASEAN Sectoral MRA on GMP Inspection the LIS * HSA, Singapore (since 1 Jan 2000) * NPCB, Malaysia (since 1 Jan 2000) * BPOM, Indonesia (since 1 Jul 2002) * FDA, Thailand (since 13 Mar 2015) - officially applied in Jun.2012 (via ASEAN PoE route) - ASEAN PoE assessment of ThaiFDA, week of 8-12 Sep.2014) - the 22 nd PPWG Meeting, agreed and endorsed ThaiFDA as listed Inspection Service under the ASEAN Sectoral MRA on GMP Inspection for Manufacturers of Medicinal Products, as submitted by the JSC GMP MRA. Ref. Mr.Sia Chong Hock/Chair of JSC GMP MRA
25 ASEAN PPWG MRA on GMP Inspection (3) Benefits of ASEAN MRA on GMP Inspection & LIS * avoiding duplication of GMP Audits within ASEAN * saving time, resources & costs for Regulators& Industry * facilitating Trade in Medicinal Products across ASEAN * quicker access of Medicinal Products by ASEAN Patients * harmonizing ASEAN Inspection System to that of PIC/S * increase Attractiveness of ASEAN to investors of larger economies Ref. Mr.Sia Chong Hock/Chair of JSC GMP MRA
26 ASEAN PPWG MRA on GMP Inspection (4) Looking Beyond AEC 2015 * increase # of ASEAN LIS - PhFDA: 8 Mar.2015 officially submitted Application 1 Dec.2015 an ASEAN PoE was formed to carry out a preliminary assessment (ThaiFDA-Mr.Pinpong INTARAPANICH) Currently ASEAN PoE is conducting further assessment. And when PhFDA is ready, the on-site assessment will be conducted. Final Assessment Report will then be presented to ASEAN MRA JSC & PPWG for approval/endorsement. - Viet Nam is interested to apply for ASEAN LIS * train ASEAN Inspector * Expand Scope of ASEAN MRA on GMP Inspection (include APIs, Biologics, etc) * Connect ASEAN with Asia & Rest of the World (Korea, Japan, China, USA, EU, ISPE, PIC/S, WHO, etc) Ref. Mr.Sia Chong Hock/Chair of JSC GMP MRA
27 Presentation Outline PPWG- ASEAN Harmonization ASEAN PPWG-MRA on GMP Inspection PPWG vs. ICH vs. PIC/S Direction & Guidance
28 Global/Regional Regulatory Harmonization/Convergence/Coop. Scope - Technical, Guideline, Procedure Coverage - NCEs, Generic, Herbal med.,.. Topic - GMP Inspection, Drug Evaluation, PQP, etc WHO (>190 countries) ICH (EU+Japan+USA) PIC/S (DRAs & ICH & WHO-PQ) RHSC (APEC-LSIF) PWGs /AWGPD (ASEAN) PANDRH (Pan American) SADC (South Africa) GCC (Middle East) BIMST-EC (South Asia)
29 ICH & ASEAN-PPWG& PIC/S & WHO EU+Japan+USA ICH ICH ASEAN PPWG Since 1990 Reform in Jan.2016 Since 1999 NMEs NMEs & Generic Top 3 Countries/Region of the World R&D 10 ASEAN Countries Initiator : - Harmonization Model - Q/S/E/M Technical Guidelines Utilizer ICH Model & Tech. gls. ASEAN PPWG ASEAN PPWG invited Observer to GCG/ICH PIC/S & WHO Expert in ICH-EWG, i.e. Q7 etc.
30 ASEAN PPWG vs. ICH Technical gls. Current valid gls.(step 5, as of 10 Mar.15) 108 gls. ICH tech. gls. Total New PPWG-Adoption Efficacy (E) Safety (S) Quality (Q) Multidisciplinary Adoption/Not-adoption by PPWG (as adopted gls., accept as reference gls., not-adopted) 22 nd PPWG Meeting noted recommendation to consider make use of Quality and Multidisciplinary Guidelines 30
31 Presentation Outline PPWG- ASEAN Harmonization ASEAN PPWG-MRA on GMP PPWG vs. ICH vs. PIC/S Direction & Guidance
32 ASEAN Leaders MANDATES Tasks to Members AFTA AEC Int l Std. Facilitate Trade Harmonization Requirement Std. & Conformance Common Requirements MRA
33 Overall Process in Thailand Regional Agreement-Implementation - ASEAN Following & Strengthening!
34 PPWG- Post 2015 Activities Principle 1. Sectoral MRA on GMP Inspection for Manufacturers of Medicinal Products a. increase # of LIS via either PIC/S membership or PoE route b. Capacity Building c. Expand scope of MRA to include APIs and Biologics, when 5 or more NDRAs have been included in LIS d. Development of new guidelines in the area of Biologics including Cell and Gene Therapy 2. ACTD/ACTR a. Include requirements for biologics in ACTR/ACTD b. updated & expanded version of ACTD/ACTR, i.e vaccine c. Development of technical guideline related to vaccine d. Joint Assessment Scheme & Regulatory Framework 3. ASEAN Sectoral MRA on BE Study Report a. Signing MRA on BE Study Report b. Establishing the requirements, rules and procedures for the JSC... c. Evaluate the structure of ACCSQ-PPWG to accommodate the JSC of BE Study Report d. Establishing the requirements, rules and procedures for Panel of Experts (PoE) e. Awareness Raising and Readiness of BE Centre f. PoE Establishment g. Capacity building for inspector (NDRA) of BE and BE centres, including Joint Inspection with AMS for overseas inspection h. Implementation of MRA on BE Study Report 4. Expand scope of PMAS - to include Adverse Events Following Immunisation (AEFI) since ACTR/ACTD now includes Biologics 5. Participation of PPWG rep. in the international org., such as ICH, PIC/S, European Pharmacopeia Commission 6. Cooperation with WHO/ Dialogue Partners/International Organization (i.e. ICH, PIC/S, MFDS,) 7. Collaboration with Private Sectors, i.e APC and APRIA and other relevant stakeholders 8. Possible establishment of an ASEAN vaccine manufacturing programme
35 ICH Quality Guidelines Q1A-Q1F Stability Q2 Analytical Validation Q3A-Q3D Impurities Q4A-Q4B Pharmacopoeias Q5A-Q5E Quality of Biotechnological Products Q6A-Q6B Specification Q7 Good Manufacturing Practice Q7-Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients- Q7 Q&AsQuestions and Answers: -Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients Q8 Pharmaceutical Development Q8(R2)-Pharmaceutical Development Q8/9/10 Q&AsR4-Q8/Q9/Q10 Implementation Q9 Quality Risk Management Q9-Quality Risk Management Q8/9/10 Q&AsR4-Q8/Q9/Q10 - Implementation Q10 Pharmaceutical Quality System Q10-Pharmaceutical Quality System Q8/9/10- Q&AsR4Q8/Q9/Q10 - Implementation Q11 Development and Manufacture of Drug Substance Q11-Development and Manufacture of Drug Substances (Chemical Entities and Biotechnological/Biological Entities) Q11 Q&AsQuestions & Answers: Selection and Justification of Starting Materials for the Manufacture of Drug Substances Q12 Lifecycle Management Q12-Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management
36 Perspective- Guidance Understand ASEAN Sectoral MRA for GMP Inspection Get Ready for Expansion on Scope of the MRA Study PIC/S Requirement & Guidances Study ICH Quality Guidelines- Q7-Q12 Work/Cooperation, closely, with ThaiFDA
37 Stronger Together!!!
ASEAN Regulatory Harmonization Scheme Overview &
ASEAN Regulatory Harmonization Scheme Overview & Pharmaceuticals Regulatory Harmonization Update By Yuppadee JAVROONGRIT, Ph.D. Senior Expert on Pharmaceuticals Standard Food and Drug Administration (ThaiFDA)
More informationASEAN Pharmaceutical Harmonization Updates. Abida Syed M Haq Ministry of Health, Malaysia
ASEAN Pharmaceutical Harmonization Updates Abida Syed M Haq Ministry of Health, Malaysia Presentation Outline About ASEAN Background Economic Integration Current Status Issues & Challenges Efforts by Malaysia
More informationCOPING WITH INCREASING NEEDS FOR INSPECTIONS: ASEAN INITIATIVES. Abida Syed M Haq Ministry of Health, Malaysia
COPING WITH INCREASING NEEDS FOR INSPECTIONS: ASEAN INITIATIVES Abida Syed M Haq Ministry of Health, Malaysia Presentation Outline About ASEAN Background Economic Integration Current Scenario Acceptable
More informationASEAN STANDARDS AND CONFORMANCE STRATEGIC PLAN FORGING AHEAD TOGETHER: ENSURING QUALITY & BUILDING CONFIDENCE
ASEAN STANDARDS AND CONFORMANCE STRATEGIC PLAN 2016-2025 FORGING AHEAD TOGETHER: ENSURING QUALITY & BUILDING CONFIDENCE 1 Introduction 1. The ASEAN Leaders at their Summit in Kuala Lumpur in December 1997
More informationRegional Update ASEAN PPWG
Regional Update ASEAN PPWG by Yuppadee JAVROONGRIT, Ph.D. Co-Chair of ACCSQ/PPWG, ASEAN ThaiFDA, Thailand The ICH-Global Cooperation Group Meeting The Hilton San Diego Bay Front Hotel, San Diego, CA, USA
More informationTrade and Facilitation
Trade and Facilitation Trade and Facilitation Trade Facilitation in ASEAN As Brunei Darussalam, Indonesia, Malaysia, Philippines, Singapore and Thailand have eliminated the import duties on 99.65% of traded
More informationFramework for implementing risk analysis in ASEAN
1 2 Framework for implementing risk analysis in Topic 1. National food control system & Risk Analysis 2. Activities on risk analysis in 3.Challenges and Recommendations for Mr.Wanchai Srithongkham Representative
More informationSumalee Tangpitayakul Department of Science Service Thailand
Current Status on Regulations and Standards for Food Contact Materials in ASEAN Sumalee Tangpitayakul Department of Science Service Thailand E-mail: sumalee@dss.go.th ILSI SEA Region 6th Asian Conference
More informationAPPENDIX I ROADMAP FOR INTEGRATION OF HEALTHCARE SECTOR
APPENDIX I ROADMAP FOR INTEGRATION OF HEALTHCARE SECTOR I. OBJECTIVES The objectives of this initiative are to: - Strengthen regional integration through liberalisation and facilitation measures in the
More informationGlobal Development of Drugs and Co-operation among Asian Economies
Global Development of Drugs and Co-operation among Asian Economies Chi-Chou Liao, Ph.D. Director General Bureau of Pharmaceutical Affairs, Department of Health, Chinese Taipei 2006 Symposium on Asia Pacific
More informationNorrani Eksan Ministry of Health Malaysia
Making Regulations work for regional and Global Trade ASEAN Perspective from Malaysia Harmonization of food safety in ASEAN Norrani Eksan Ministry of Health Malaysia Cii Regulatory summit India 16-17 Oct
More informationAsia Pacific Logistics Federation. Mr. David Rogers APLF Chairman
Asia Pacific Logistics Federation Mr. David Rogers APLF Chairman Vietnam presentation: 16-July-2016 Asia Pacific Logistics Federation To be the lead advocacy for supply chains and logistics in the Asia
More informationRegulatory Requirements for Registration of Generic Products in Singapore & Thailand
ISSN 2395-3411 Available online at www.ijpacr.com 651 Review Article Regulatory Requirements for Registration of Generic Products in Singapore & Thailand Sripathi Bhavya sri Department of Pharmaceutical
More informationAEC Alert: Challenges and Opportunities in Trade in Services. Daw Myat Myat So
AEC Alert: Challenges and Opportunities in Trade in Services Daw Myat Myat So 1 Introduction 1. What is AEC? 2. Progress Status of ASEAN Trade in Services: What have been achieved and How to move forward?
More informationStrengthening the Regulation of Medical Products through Networking, Cooperation & Harmonization
Strengthening the Regulation of Medical Products through Networking, Cooperation & Harmonization Daniela Decina Technical Officer Regulatory Systems Strengthening Current challenges in low- and middle-income
More informationUS FDA and International Regulatory Efforts in Cellular and Gene Therapies
US FDA and International Regulatory Efforts in Cellular and Gene Therapies ISCT Satellite Global Regulatory Perspectives Workshop January 27, 2013 Kimberly Benton, Ph.D. Deputy Director, Division of Cellular
More informationQ&A on ICH Q7 Good Manufacturing Practice Questions and Answers Document
Q&A on ICH Q7 Good Manufacturing Practice Questions and Answers Document March 2017 International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use 1 ICH Q7 - Questions
More informationUpdates. APEC Life Science and Innovation Forum Regulatory Harmonization Steering Committee (APEC LSIF-RHSC) HO CHI MINH VIET NAM, August, 2017
Updates APEC Life Science and Innovation Forum Regulatory Harmonization Steering Committee (APEC LSIF-RHSC) HO CHI MINH VIET NAM, 18-19 August, 2017 Ministry of Health Republic of Indonesia ARIANTI ANAYA
More informationJapan-ASEAN Cooperation and Japan's initiative for AJCEP and RCEP. 8 August 2018 Ministry of Economy, Trade and Industry Kunihiko SHINODA
Japan-ASEAN Cooperation and Japan's initiative for AJCEP and RCEP 8 August 2018 Ministry of Economy, Trade and Industry Kunihiko SHINODA ASEAN-JAPAN Cooperation towards Innovation-led Inclusive Growth
More informationJapanese Pharmacopoeia s Challenge to the Globalization
Japanese Pharmacopoeia s Challenge to the Globalization Naoyuki Yabana, Ph.D. Division of Pharmacopoeia and Standards for Drugs, Office of Standards and Guidelines Development, Pharmaceuticals and Agency
More informationCMC Strategy Forum Japan November Piyanan Boonprasirt Bureau of Drug Control Thailand Food and Drug Administration
CMC Strategy Forum Japan 2015 9-10 November 2015 Piyanan Boonprasirt Bureau of Drug Control Thailand Food and Drug Administration 1 1. Background 2. Organization Chart 3. Biological Products 4. Regulation
More informationEmerging governance mechanisms in ASEAN: Supporting improved quality infrastructure for forest sector legality and sustainability initiatives
Asia-Pacific Forestry Week Stream 4: New institutions, new governance Emerging governance mechanisms in ASEAN: Supporting improved quality infrastructure for forest sector legality and sustainability initiatives
More informationChallenges and Opportunities in the Global Regulatory Environment
Challenges and Opportunities in the Global Regulatory Environment Diane Zezza, Ph.D. Novartis Pharmaceuticals Corporation WCBP 2013 January 29, 2013 Diversity and Global Landscape Development Registration
More informationASEAN s Approach on Codex. Pisan Pongsapitch National Bureau of Agricultural Commodity and Food Standards (ACFS), Thailand
ASEAN s Approach on Codex Pisan Pongsapitch National Bureau of Agricultural Commodity and Food Standards (ACFS), Thailand 1 ASEAN s Approach for Applying Scientific Principle and Risk Analysis for Food
More informationA.1 Contents file 4 to 5 A.1 (1)
Contents file 4 to 5 Contents file 4 to 5 A Information Contents file 4 to 5 A.2 Index file 4 to 5 A.3 List of Abbreviations A.4 Glossary A.5 Adress-Register A.6 References B Japanese Regulations B.1 MHW
More informationContents APEC Harmonization Center(AHC)
Contents APEC Harmonization Center(AHC) I. AHC- A Brief Overview II. Inauguration Ceremony of AHC III. Multi-Regional Clinical Trial Workshop IV. Biosimilar Workshop V. Next Steps AHC Vision Establishment
More information2016/LSIF/FOR/005 Delivering New Treatments to Patients in Chinese Taipei
2016/LSIF/FOR/005 Delivering New Treatments to Patients in Chinese Taipei Submitted by: Chinese Taipei Policy Forum on Strengthening Surveillance and Laboratory Capacity to Fight Healthcare Associated
More informationGreening the Economy in ASEAN. ASEAN Secretariat
Greening the Economy in ASEAN ASEAN Secretariat Outline -ASEAN Policy Framework- -Priority Areas of ASEAN Cooperation on Environment- -Highlights of AMS Initiatives on Greening the Economy- -Highlights
More informationAPPENDIX I ROADMAP FOR INTEGRATION OF AUTOMOTIVE PRODUCTS SECTOR
APPENDIX I ROADMAP FOR INTEGRATION OF AUTOMOTIVE PRODUCTS SECTOR I. OBJECTIVES The objectives of integrating the automotive sector are: - Strengthen regional integration efforts through liberalisation,
More informationRegulations of Biologics in Taiwan
Regulations of Biologics in Taiwan Churn-Shiouh Gau, Ph.D. Executive Director, Taiwan 2013/2/13 1 Outlines Regulation of Drugs in Taiwan - Organizations Regulations for Marketing Approval for Drugs including
More informationGuidelines for the Development of Mutual Recognition Arrangements
Guidelines for the Development of Mutual Recognition Arrangements ASEAN Consultative Committee on Standards & Quality 20 May, 2016 Second Edition Abbreviations AEC ACCSQ AMS ATIGA CLMV MRA NTB PWG SDoC
More informationBiosimilar Regulation in the ASEAN
Biosimilar Regulation in the ASEAN Shivraj Dasari, Ph.D., Managing Director, SLS Cell Cure Technologies Private Limited, Flat#103, Prabhat Apartments, Street No.11,East Marredpally, Secunderabad 500026,Tel/Fax
More informationWork plan for the GMP/GDP Inspectors Working Group for 2018
30 November 2017 EMA/INS/GMP/504401/2017 Inspections, Human Medicines Pharmacovigilance & Committees Division Work plan for the GMP/GDP Inspectors Working Group for 2018 Chairperson: Brendan Cuddy Adopted:
More informationCURRENT STATUS OF PAN AMERICAN NETWORK FOR DRUG REGULATORY HARMONIZATION (PANDRH):
CURRENT STATUS OF PAN AMERICAN NETWORK FOR DRUG REGULATORY HARMONIZATION (PANDRH): OVERVIEW AND WORKING GROUP UPDATES James Fitzgerald Advisor Essential Medicines and Biologicals PAHO Washington DC PANDRH:
More informationSLOM WORKING GROUP ON PROGRESSIVE LABOUR PRACTICES TO ENHANCE THE COMPETITIVENESS OF ASEAN (SLOM-WG) WORK PLAN
Adopted by the 24 th ALMM SLOM WORKING GROUP ON PROGRESSIVE LABOUR PRACTICES TO ENHANCE THE COMPETITIVENESS OF ASEAN (SLOM-WG) WORK PLAN 2016-2020 ASCC Vision 2025 An ASEAN Community that engages and benefits
More informationSLOM WORKING GROUP ON PROGRESSIVE LABOUR PRACTICES TO ENHANCE THE COMPETITIVENESS OF ASEAN (SLOM-WG) WORK PLAN
Adopted by the 24 th ALMM SLOM WORKING GROUP ON PROGRESSIVE LABOUR PRACTICES TO ENHANCE THE COMPETITIVENESS OF ASEAN (SLOM-WG) WORK PLAN 2016-2020 ASCC Vision 2025 An ASEAN Community that engages and benefits
More informationKey Outcomes of the 49 th ASEAN Economic Ministers Meeting and Related Meetings 7-11 September 2017, Pasay City, Philippines
Key Outcomes of the 49 th ASEAN Economic Ministers Meeting and Related Meetings 7-11 September 2017, Pasay City, Philippines The 49th ASEAN Economic Ministers (AEM) Meeting was held on 7 September 2017
More informationUPDATES ON THE ASEAN MEMBER STATES. Washington, September 2014
UPDATES ON THE ASEAN MEMBER STATES Washington, September 2014 WHERE WILL BE THE ASEAN COMMUNITY MEDICAL DEVICE SECTOR BY 2020? HOW IS IT GOING TO GIVE A BUSINESS IMPACT IN THE MEDICAL DEVICE SECTOR? Facts
More informationAppropriate Control Strategies Eliminate the Need for Redundant Testing of Pharmaceutical Products
Date: April 23, 2012 Appropriate Control Strategies Eliminate the Need for Redundant Testing of Pharmaceutical Products Key Messages Importation quality control testing for pharmaceutical, biological/biotechnology
More informationOptimising the management of post-approval changes for patients timely access to medicines
Optimising the management of post-approval changes for patients timely access to medicines The industry perspectives with a Pledge for Convergence 7th APAC, April 2018 Sannie Chong (Ph.D. FRSC) Asia Pacific
More informationThe pessimist sees difficulty in every opportunity, the optimist sees the opportunity in every difficulty. Churchill, Winston
The pessimist sees difficulty in every opportunity, the optimist sees the opportunity in every difficulty. Churchill, Winston Expectations are same: Safety Efficicacy GMP compliance Profile attribute Population
More informationProfessor (Dr.) Amita Batra Professor of Economics Centre for South Asian Studies School of International Studies JNU
Professor (Dr.) Amita Batra Professor of Economics Centre for South Asian Studies School of International Studies JNU Mega-regional Trade Agreements Theoretical argument: Second best option RCEP, TPP Driver:
More informationCurrent GMP Inspection of PMDA. Shingou SAKURAI, Ph.D Office of Compliance and Standards Pharmaceuticals and Medical Devices Agency(PMDA), JAPAN
Current GMP Inspection of PMDA Shingou SAKURAI, Ph.D Office of Compliance and Standards Pharmaceuticals and Medical Devices Agency(PMDA), JAPAN GMP Inspection related Organizations in Japan Organizations
More informationSection I: Pharmaceuticals and Medical Devices
SUPPLEMENT on HEALTHCARE INNOVATION Visionary Goals and Recommendations 51th Japan-U.S. Business Conference Japan-U.S. Business Council / U.S.-Japan Business Council November 14, 2014 The R&D-based pharmaceutical
More informationAPEC s Sustainable Economic Development & Economic Integration Through ICT/Electronics
2008/SOM1/MAG/WKSP/009 Session: 3 APEC s Sustainable Economic Development & Economic Integration Through ICT/Electronics Submitted by: Matsushita Electric Industrial Co. Workshop on Information Technology
More informationComparison of Marketing Authorisation and its Requirements for Brunei Darussalam and Indonesia
Comparison of Marketing Authorisation and its Requirements for Brunei Darussalam and Indonesia Abstract: The availability of generic medication is an important issue in the ASEAN region. The regulatory
More informationKorea GMP & DMF. April Korea Pharmaceutical Traders Association Deputy director Oh Hyun, Kwon
Korea GMP & DMF April. 2015 Korea Pharmaceutical Traders Association Deputy director Oh Hyun, Kwon Contents 1. KPTA 2. Pharmaceutical industry 3. KGMP 4. KDMF KPTA KPTA Purpose ㅇ Trade promotion of pharmaceuticals,
More informationPROPOSED DOCUMENT. Asian Harmonization Working Party Strategic Framework Towards "The Foreseeable Harmonization Horizon"
PROPOSED DOCUMENT Title: Asian Harmonization Working Party Strategic Framework Towards 2020 - "The Foreseeable Harmonization Horizon" Authoring Group: AHWP OFFICE BEARERS Date: September 20 th, 2012 This
More informationWork plan for the GMP/GDP Inspectors Working Group for 2017
13 January 2017 EMA/INS/GMP/584202/2016 Work plan for the GMP/GDP Inspectors Working Group for 2017 Chairperson: David Cockburn Adopted: December 2016 1. Meetings scheduled for 2017 Face-to-face meetings
More informationRegulation of Active Pharmaceutical Ingredients (API)
Regulation of Active Pharmaceutical Ingredients (API) Stephan Rönninger Head External Affairs Europe, International Quality June 21, 2013 SINDUSFARMA / ANVISA / FIP-IPS Conference, Brasilia Agenda Regulations
More informationThe 2015 ASEAN Community Building & Post-2015 ASEAN. AKP Mochtan Deputy Secretary-General Community & Corporate Affairs ASEAN
The 2015 ASEAN Community Building & Post-2015 ASEAN AKP Mochtan Deputy Secretary-General Community & Corporate Affairs ASEAN ASEAN: Association of South East Asian Nations 10 MEMBER STATES Brunei Darussalam
More informationKirsten L. Vadheim, Ph.D. BioCompliance Consulting, Inc. Presented at the ASBM Forum, February 25, 2014, Washington DC
Kirsten L. Vadheim, Ph.D. BioCompliance Consulting, Inc. Presented at the ASBM Forum, February 25, 2014, Washington DC klvadheim@hotmail.com The Importance of Data Over Time 2003: FDA approved innovator
More informationASEAN GOOD REGULATORY PRACTICE (GRP) GUIDE
Endorsed by the 2/40 SEOM Meeting 2-4 February 2009, Bangkok, Thailand ASEAN GOOD REGULATORY PRACTICE (GRP) GUIDE BACKGROUND Differences in the regulatory requirements of individual Member States are among
More informationfact sheet 7 Regulator Capacity for Biologics in Low-and- Middle Income Countries
fact sheet 7 Regulator Capacity for Biologics in Low-and- Middle Income Countries International Alliance of Patients Organizations CAN Mezzanine 49-51 East Road London N1 6AH United Kingdom International
More informationICH Q12 : A Unique Opportunity to Realize 21st Century Quality Vision
ICH Q12 : A Unique Opportunity to Realize 21st Century Quality Vision Moheb M. Nasr 3rd FDA/PQRI Conference March 22, 2017 Disclosures The speaker is solely responsible for the content of this presentation
More information2000 E-ASEAN FRAMEWORK AGREEMENT
Signed in Singapore on 24 November 2000 PREAMBLE... 2 ARTICLE 1 DEFINITION... 3 ARTICLE 2 OBJECTIVES... 3 ARTICLE 3 COVERAGE... 3 ARTICLE 4 FACILITATION OF THE ESTABLISHMENT OF THE ASEAN INFORMATION INFRASTRUCTURE...
More informationASEAN GOOD REGULATORY PRACTICE (GRP) GUIDE
Adopted at the 22 nd WG 1 Meeting 10-11 July 2008, Singapore ASEAN GOOD REGULATORY PRACTICE (GRP) GUIDE BACKGROUND Differences in the regulatory requirements of individual member countries are among those
More informationICH Q11 Development & manufacture of drug substances
ICH Q11 Development & manufacture of drug substances Keith McDonald Group Manager Medicines & Healthcare products Regulatory Agency (UK) 2011 ICH International Conference on Harmonisation of Technical
More informationEMA and international cooperation
EMA and international cooperation The EU medicines regulatory system and the European Medicines Agency: an introduction for international regulators and non-governmental organisations London, 18-19 September
More informationCapacity Building Assistance: Moral Imperative or Common Sense?
Capacity Building Assistance: Moral Imperative or Common Sense? Global Food Safety Policy Forum Washington DC, October 14 th 2009 Paul B Young, PhD Waters Corporation 2008 Waters Corporation Proposals
More informationAn overview of international initiatives in the regulatory sphere
The place of the Certification Procedure in the global regulatory environment 19/20 September 2017, Prague, Czech Republic An overview of international initiatives in the regulatory sphere Cordula Landgraf
More informationCMC Workshop CMC Challenges in Japan. April Bethesda, MD. Yoshihiro Matsuda, Ph.D., PMDA Session 10
CMC Workshop 2015 April 13-15 Bethesda, MD CMC Challenges in Japan Yoshihiro Matsuda, Ph.D., PMDA Session 10 Disclaimer The views and opinions expressed in the following PowerPoint slides are those of
More informationCTA/NDA Regulatory Landscape in China. Jack Xie, PhD, DABT SOT 2016
CTA/NDA Regulatory Landscape in China Jack Xie, PhD, DABT SOT 2016 Disclaimer The content of the following presentation represents solely author s view and may not reflect any position of Roche or China
More informationRegulatory Updates in Taiwan
6th Joint Conference of Taiwan and Japan on Medical Products Regulation Regulatory Updates in Taiwan Shou-Mei Wu, Taiwan Food and Drug Administration Oct. 11, 2018 Outlines 01 02 03 04 05 06 Mission, Vision,
More informationAsia Pacific Economic Co-operation (APEC) Principles for voluntary codes of business ethics
Asia Pacific Economic Co-operation (APEC) Principles for voluntary codes of business ethics Chrisoula Nikidis Executive Director, Ethics and Compliance, Rx&D Canada The Asia-Pacific Pharmaceutical Compliance
More informationMoving ASEAN forward, Strengthening Community Building
Moving ASEAN forward, Strengthening Community Building Special Address by H.E. Le Luong Minh, Secretary General of ASEAN at the 10 th ASEAN Leadership Forum Sunway Resort Hotel & Spa, Kuala Lumpur, Malaysia;
More informationUpdate of AHC Activities. Kui Lea Park, Ph.D Director, Center for Drug Development Assistance, KFDA APEC Harmonization Center
Update of AHC Activities Kui Lea Park, Ph.D Director, Center for Drug Development Assistance, KFDA APEC Harmonization Center November 13 th, 2012 Contents I Overview of 2012 Activities II Planning of 2013
More informationICH Q10/WHO TRS A Regulatory Perspective
Presentation by: Dr. A. Ramkishan Asst. Drugs Controller (India) Govt. of India ICH Q10/WHO TRS A Regulatory Perspective Contents of Presentation Introduction History of WHO GMP TRS guidelines A Unique
More information1. GMP/Quality issues Report back from the discussion in last year s symposium
2 nd Japan - India Medical Products Regulation Symposium 1. GMP/Quality issues Report back from the discussion in last year s symposium Mr. Fumihito Takanashi, Office of International Regulatory Affairs
More informationInternational Regulatory Convergence
International Regulatory Convergence - Is Enough Being Done? Bob Tribe, 11 July 2016 1 Why Improve Regulatory Convergence? Many different efforts promoting regulatory convergence. These efforts are fragmented
More informationEconomic Research Institute for ASEAN and East Asia, 2016
Economic Research Institute for ASEAN and East Asia, 2016 ERIA Research Project FY2015 No.15 Published in November 2016 All rights reserved. No part of this publication may be reproduced, stored in a retrieval
More informationLatest Trend of Drug Quality in Korea In-Kyu Kim, Ph.D. Division Director Drug Evaluation Department
Latest Trend of Drug Quality in Korea 2008. 4.14 In-Kyu Kim, Ph.D. Division Director Drug Evaluation Department Contents Status of KFDA CMC, GRP and CTD DMF GMP Quality Control on the market International
More informationInternational Regulatory Harmonisation A Challenge
Dr. Milind Joshi President - Global Regulatory Management International Regulatory Harmonisation A Challenge www.jbcpl.com Copyright 2005 J. B. Chemicals Pvt. Ltd. Harmonisation in Drug Regulation Process
More informationRegulatory considerations for Global Haplobank
Regulatory considerations for Global Haplobank Jacqueline Barry Catapult is an Innovate UK programme. GTP Good Practice GMP GLP, GCP, GVP Cell & Tissue Procurement MCB production Manufacture to clinical
More informationTHREATS AND OPPORTUNITIES IN AUSTRALIA AND ASIA. October 2015 Kim Leighton Director Strategic Projects NSW Food Authority
THREATS AND OPPORTUNITIES IN AUSTRALIA AND ASIA October 2015 Kim Leighton Director Strategic Projects NSW Food Authority GLOBAL TRADE Food safety is an essential requirement for trade High profile incidents
More informationProgress of International Collaboration among Asian Countries Nobumasa Nakashima, Ph.D.
Progress of International Collaboration among Asian Countries Nobumasa Nakashima, Ph.D. Director, Office of International Programs Pharmaceuticals and Medical Devices Agency (PMDA) Disclaimer The views
More informationThird WHO Global Forum on Medical Devices. South East Asia Regional Perspective
Third WHO Global Forum on Medical Devices South East Asia Regional Perspective Medical device regulatory systems in SEAR National medicines policies exists in most countries and some of these also cover
More informationImpacto de las Nuevas Tendencias Regulatorias en la Producción de Parenterales. Innovacion en Packaging Primario
Impacto de las Nuevas Tendencias Regulatorias en la Producción de Parenterales Innovacion en Packaging Primario 1 Contents Company Highlight What s Changing in Pharma Pharma Trends Harmonisation New Requirements
More informationImpacto de las Nuevas Tendencias Regulatorias en la Producción de Parenterales
Impacto de las Nuevas Tendencias Regulatorias en la Producción de Parenterales Empaques Primarios y Tendencias Farmaceuticas para Inyectables 1 International Support Support in R&D Technology Transfer
More informationEmergent Trilateralism in Developing Asia
Emergent Trilateralism in Developing Asia Long Term Scenarios for Regional Growth and Trade Douglas Brooks, ADB David Roland-Holst, UC Berkeley Fan Zhai,, ADB presented at the ADB Dissemination Seminar
More informationGlobal Harmonization Summit Washington DC, September 18-19, 2014 Mike Ward Health Canada
Understanding Where We Have Been and Where We Are Going With Harmonization Global Harmonization Summit Washington DC, September 18-19, 2014 Mike Ward Health Canada Presentation Outline The Regulatory Lexicon:
More informationMedical Device Single Audit Program (MDSAP)
Medical Device Single Audit Program (MDSAP) Kimberly A. Trautman Executive Vice President, Medical Device International Services Health Sciences Medical Devices NSF International This document is intended
More informationImplementation of 2005 Pharmaceutical Affairs Law and ICH Q8-Q10 in Japan
JCCT workshop on Q8/Q9/Q10 Beijing Implementation of 2005 Pharmaceutical Affairs Law and ICH Q8-Q10 in Japan Yukio HIYAMA Chief, 3 rd Section, Division of Drugs National Institute of Health Sciences, Ministry
More informationPharmaceutical Reference Standards: Overview and Role in Global Harmonization
Matthew Borer, Ph.D., Advisor Pharmaceutical Reference Standards: Overview and Role in Global Harmonization 3rd DIA China Annual Meeting Beijing, China, 16-18 May, 2011 What is a Pharmaceutical Reference
More informationGlobal Biologics Regulatory Trends Challenges and Opportunities..
Global Biologics Regulatory Trends Challenges and Opportunities.. Wassim Nashabeh VP, Regulatory Policy and International Operations F.Hoffmann La-Roche, Basel, Switzerland picture placeholder Page 2 N-linked
More informationProgress Report on Recommendations of 14 th International Conference of Drug Regulatory Authorities (ICDRA) from WHO South-East Asia Region (SEAR)
Progress Report on Recommendations of 14 th International Conference of Drug Regulatory Authorities (ICDRA) from WHO South-East Asia Region (SEAR) 14 th ICDRA, Singapore, December 2010 Dr K A Holloway,
More informationEU Update on Regulatory Developments
EU Update on Regulatory Developments Pascal Venneugues European Medicines Agency CASSS CMC Strategy Forum Europe Copenhagen, 4-6 May 2015 An agency of the European Union Overview International cooperation
More informationPharmacist Rana Musa Al-ali (Malkawi) MSc (Pharmaceutical Quality Assurance) Registration Department/JFDA
Pharmacist Rana Musa Al-ali (Malkawi) MSc (Pharmaceutical Quality Assurance) Registration Department/JFDA 1 2 ND MENA Regulatory Conference On Bioequivalence, Biowaivers, Bioanalysis, Dissolution & Biosimilars
More informationExploring Areas of Learning and Cooperation on Forest Tenure Reform of Asia
Exploring Areas of Learning and Cooperation on Forest Tenure Reform of Asia Mr.Preecha Ongprasert Forest Officer Urban Forestry Development Section Community Forest Management Bureau Royal Forest Department,
More informationAPPENDIX I ROADMAP FOR INTEGRATION OF WOOD-BASED PRODUCTS SECTOR
APPENDIX I ROADMAP FOR INTEGRATION OF WOOD-BASED PRODUCTS SECTOR I. OBJECTIVES The objectives of this initiative are : - Strengthen regional integration on through liberalisation and facilitation measures
More informationGMP Compliance. George Acevedo, CQV Senior Engineer M+W Singapore Pte. Ltd
GMP Compliance George Acevedo, CQV Senior Engineer M+W Singapore Pte. Ltd June 2017 Overview GMP Definition and Regulation Our Philosophy and Strategy for Compliance Project Lifecycle Deliverables Master
More informationKorean Perspective : Recent Trends in the Regulation of Biopharmaceuticals
Korean Perspective : Recent Trends in the Regulation of Biopharmaceuticals Dec. 4, 2017 Heajeong Doh Ministry of Food and Drug Safety, Korea [ Table of Contents] Introduction of MFDS Biopharmaceuticals
More informationNATIONAL EXPERIENCES IN TVET
NATIONAL EXPERIENCES IN TVET ASEAN Context, Issues and Trends of Viet Nam Dr. Nguyen Quang Viet, TVET and Skills Development Specialist, Viet Nam Santiago de Chile, October 2016 ASEAN context Population:
More informationRegulation, Norms and Standards for medical products *
Regulation, Norms and Standards for medical products * Technical Briefing Seminar 23-27 November, 2015 Dr Lembit Rägo Head, Regulation of Medicines and other Health Technologies Essential Medicines and
More informationEuropean Union (EU) Regulatory Trends in GMP. Clive Brading Tianjin, China September 23, 2009
European Union (EU) Regulatory Trends in GMP Clive Brading Tianjin, China September 23, 2009 -2- Presentation Topics EU Background Inspections outside the EU EMEA Inspection Outcomes Dedicated Facilities
More informationPhan Thi Thanh Nhan Foreign Investment Agency (FIA) Ministry of Planning and Investment (MPI) INVESTMENT IN VIETNAM
Phan Thi Thanh Nhan Foreign Investment Agency (FIA) Ministry of Planning and Investment (MPI) INVESTMENT IN VIETNAM CONTENTS I. Why Vietnam II. FDI in Viet Nam III. Orientation in FDI attraction I. WHY
More informationto protect human health throughout the life-cycle of medicinal products;
ICMRA Communications Strategy: 2018-2020 Introduction The International Coalition of Medicines Regulatory Authorities (ICMRA) is a voluntary, highlevel, strategic coordinating, advocacy and leadership
More informationIntroduction and Update on ICH Q12 Guideline Dr Frank Montgomery, Global Head, Reg CMC, AstraZeneca/Medimmune Q12 EFPIA Expert
Introduction and Update on ICH Q12 Guideline Dr Frank Montgomery, Global Head, Reg CMC, AstraZeneca/Medimmune Q12 EFPIA Expert CMC Strategy Forum Japan 2016 6 th Dec 2016 Outline Q12 Scope and Objectives
More informationASEAN OCCUPATIONAL SAFETY AND HEALTH NETWORK (ASEAN-OSHNET) WORK PLAN
ASEAN OCCUPATIONAL SAFETY AND HEALTH NETWORK (ASEAN-OSHNET) WORK PLAN ASCC Vision 2025 An ASEAN Community that engages and benefits the peoples and is inclusive, sustainable, resilient, and dynamic ASCC
More informationASEAN INTEGRATION: THE NEXT DECADE AHEAD
ASEAN INTEGRATION: THE NEXT DECADE AHEAD Presentation by Prof. Federico M. Macaranas, PhD 39 th Annual Conference of the Integrated Electrical Engineers of the Philippines SMX Convention, Mall of Asia,
More information